Angle (AGL)

 

Latest News

Leading cancer surgeon appointed

RNS Number: 8891N Angle PLC 14 May 2018 For immediate release 14 May 2018 ANGLE plc ("the Company") LEADING NHS PROSTATE CANCER SURGEON APPOINTED AS SCIENTIFIC ADVISOR ANGLE plc (AIM:AGL OTCQX:ANPCY), a world-leading liquid biopsy company, is pleased to announce the appointment of Mr Greg L Shaw as a Scientific Adv...

Angle & QIAGEN Poster

RNS Number: 9525M Angle PLC 03 May 2018 For immediate release 3 May 2018 ANGLE plc ("the Company") ANGLE AND QIAGEN PRESENT POSTER AT LEADING CANCER CONFERENCE DEMONSTRATING UTILITY OF ANGLE'S PARSORTIX SYSTEM IN CONJUNCTION WITH QIAGEN'S ADNATEST ASSAY First joint marketing material relea...

Broker Forecast - finnCap issues a broker note on Angle PLC

finnCap today reaffirms its corporate investment rating on Angle PLC (LON:AGL) and set its price target at 108p. Broker F...

Angle reveals breakthrough in capturing cancer cells

Liquid biopsy Angle revealed Thursday the results of a recent study demonstrated a workflow for the recovery and cultu...

All News

DateHeadlineSource
14-05-18Leading cancer surgeon appointedRNS
03-05-18Angle & QIAGEN PosterRNS
19-04-18Broker Forecast - finnCap issues a broker note on Angle PLCStockMarketWire
19-04-18Angle reveals breakthrough in capturing cancer cellsStockMarketWire
19-04-18Parsortix in multiple presentations at AACRRNS
19-04-18Breakthrough Research with ParsortixRNS
05-04-18Angle enrols first patient into its study for metastatic breast cancer StockMarketWire
05-04-18First patient enrolled in FDA studyRNS
26-03-18Price Monitoring ExtensionRNS
26-03-18Research UpdateRNS
06-02-18Angle collaborates with Abbott for cancer analysis researchStockMarketWire
06-02-18ANGLE plc: RESEARCH GRANT FROM ABBOTTRNS
02-02-18Six AIM pharma shares on verge of breakthroughInteractive Investor
31-01-18Angle reports operational losses widen StockMarketWire
31-01-18Interim ResultsRNS
23-01-18Angle PLC to present on 28 February 2018 at the Shares and AJ Bell Spotlight Evening in EdinburghStockMarketWire
23-01-18Angle PLC to present on 20 February 2018 at the Shares and AJ Bell Spotlight Evening in ManchesterStockMarketWire
16-01-18Professor to present webinar on use of ANGLE's Parsortix StockMarketWire
16-01-18WEBINAR:USING PARSORTIX TO TEST DRUGS ON LIVE CTCSRNS
10-01-18Notice of ResultsRNS
08-01-18ANGLE reports new research on Parsortix StockMarketWire
08-01-18ANGLE plc:Prostate cancer ARV7 treatment biomarkerRNS
27-12-17Holding(s) in CompanyRNS
12-12-17Transfer of Lock-in SharesRNS
08-12-17PARSORTIX POTENTIAL IN METASTATIC BREAST CANCERRNS
28-11-17Study shows out-performance of Parsortix, says ANGLEStockMarketWire
28-11-17Parsortix enables CTC molecular characterisationRNS
23-11-17ANGLE collaboration with Philips StockMarketWire
23-11-17PHILIPS COLLABORATION IN BREAST AND RECTAL CANCERRNS
17-11-17Holding(s) in CompanyRNS
16-11-17Total Voting Rights and Covington SubscriptionRNS
13-11-17Angle to present on 28 November 2017 at the Shares and AJ Bell Spotlight Evening in LondonStockMarketWire
06-11-17Holding(s) in CompanyRNS
06-11-17Holding(s) in CompanyRNS
06-11-17Holding(s) in CompanyRNS
02-11-17Holding(s) in CompanyRNS
01-11-17ANGLE completes Axela deal and fundraising StockMarketWire
01-11-17ANGLE: Completion of Fundraising and AcquisitionRNS
31-10-17All resolutions passed at AGM of AngleStockMarketWire
31-10-17Result of AGMRNS

RSS feeds

  • Editorial news feed for LSE:AGL Editorial
  • Regulatory news feed for LSE:AGL Regulatory